Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?

We would like to thank H. Slabbynck and co-workers for their interest in the 2019 European Society of Cardiology/European Respiratory Society guidelines on the diagnosis and management of acute pulmonary embolism (PE), and for their interesting comment on the treatment duration of patients with a high-risk PE secondary to a major transient/reversible risk factor.

Source: European Respiratory Journal - January 29, 2020 Category: Respiratory Medicine Authors: Meyer, G., Konstantinides, S. Tags: Original Articles: Correspondence Source Type: research